Results 101 to 110 of about 484,316 (264)
Log-linear model based behavior selection method for artificial fish swarm algorithm. [PDF]
Comput Intell Neurosci, 2015 Huang Z, Chen Y.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan +5 more
wiley +1 more source
Bıldırcın Hatlarının Tanımlanmasında Arilesteraz Tiplerinin Kullanılabilirliğinin Belirlenmesi
Journal of Agricultural Sciences, 1999 çal ışı lan 4 farkl ı japon b ı ld ı rc ı n ı hatt ı nda arilesteraz tipleri belirlenmi ş ve EsA` fenotiplerinin frekanslar ı yüksek bulunmuştur. Log-doğ rusal model kullan ı larak b ı ld ı rc ı n populasyonlar ı nda fenotip ve genotip gruplar ı n ı n ...
Mehmet Ali Yıldırım +2 more
doaj
Utilization of primary and secondary medical care among disadvantaged populations: a log-linear model analysis. [PDF]
Glob J Health Sci, 2014 Din GY, Zugman Z, Khashper A.
europepmc +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Background and Purpose White matter hyperintensities (WMH) are a core neuroimaging marker of cerebral small vessel disease (CSVD). Sleep apnoea (SA) is a recognized vascular risk factor, but its associations with regional WMH burden, short‐interval WMH change and cognitive performance in population‐based cohorts remain incompletely defined. We
Peng Cheng +4 more
wiley +1 more source
Estimating global migration flow tables using place of birth data
Demographic Research, 2013 BACKGROUND International migration flow data often lack adequate measurements of volume, directionand completeness. These pitfalls limit empirical comparative studies of migration andcross national population projections to use net migration measures or ...
Guy J. Abel
doaj
Dimethyl Fumarate, But Not Rituximab, Reduces Serum GFAP Levels and PIRMA in Relapsing–Remitting MS
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Serum neurofilament light chain (sNfL) and glial fibrillary acidic protein (sGFAP) levels are believed to reflect mainly acute and chronic disease processes in multiple sclerosis (MS), respectively. In this study, we investigated whether dimethyl fumarate (DMF) and rituximab (RTX) differentially affect these biomarkers.
F. Shawket +14 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi +9 more
wiley +1 more source
Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin +11 more
wiley +1 more source
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective We aim to comprehensively analyze how regional tumor and edema characteristics are associated with clinical presentations and survival outcomes in a large cohort of glioblastoma patients. Methods Patients with IDH‐wildtype glioblastoma who received brain MRI from 2010 to 2023 were included.
Daniel J. Zhou +16 more
wiley +1 more source